Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Aslan Pharmaceuticals Ltd
Cash from Financing Activities
Aslan Pharmaceuticals Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
|
Cash from Financing Activities
$16.3m
|
CAGR 3-Years
70%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aslan Pharmaceuticals Ltd's Cash from Financing Activities?
Cash from Financing Activities
16.3m
USD
Based on the financial report for Sep 30, 2023, Aslan Pharmaceuticals Ltd's Cash from Financing Activities amounts to 16.3m USD.
What is Aslan Pharmaceuticals Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
70%
Over the last year, the Cash from Financing Activities growth was -84%. The average annual Cash from Financing Activities growth rates for Aslan Pharmaceuticals Ltd have been 70% over the past three years .